Eric Andrew Perez v. Dr. Neil C. Evans, et al.

CourtDistrict Court, S.D. New York
DecidedSeptember 25, 2025
Docket1:24-cv-00356
StatusUnknown

This text of Eric Andrew Perez v. Dr. Neil C. Evans, et al. (Eric Andrew Perez v. Dr. Neil C. Evans, et al.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Eric Andrew Perez v. Dr. Neil C. Evans, et al., (S.D.N.Y. 2025).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK --------------------------------------------------------- X : ERIC ANDREW PEREZ, : : Plaintiff, : : 24-CV-356 (VSB) (SN) - against - : : OPINION & ORDER DR. NEIL C. EVANS, et al., : : Defendants. : : --------------------------------------------------------- X

Appearances:

Eric Andrew Perez San Antonio, FL Pro se Plaintiff

Rebecca Lynn Salk United States Attorney’s Office for the Southern District of New York New York, NY Counsel for Defendants Dr. Neil C. Evans, Carol Johnson, George Reed Grimes, Damian Williams, and Melanie Jay

Jodyann Galvin Cheyenne Nicole Freely Hodgson Russ LLP Buffalo, NY Counsel for Defendant Dr. Mark J. Mulligan

Alexander Cousins Arthur Edward Brown Arnold & Porter Kaye Scholer LLP New York, NY Counsel for Defendants AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Ltd. VERNON S. BRODERICK, United States District Judge: Before me are pro se Plaintiff Eric Andrew Perez’s objections to Magistrate Judge Sarah Netburn’s Report and Recommendation, which recommends that I dismiss Plaintiff’s Amended Complaint with prejudice. For the reasons that follow, Plaintiff’s objections are OVERRULED, Judge Netburn’s Report and Recommendation is ADOPTED in its entirety, and Plaintiff’s

Amended Complaint is DISMISSED with prejudice. Factual Background Plaintiff Eric Andrew Perez (“Plaintiff” or “Perez”), a veteran of the United States Marine Corps, participated in a clinical trial of AstraZeneca’s COVID-19 vaccine at the Department of Veterans Affairs (“VA”). (Doc. 37 (“Am. Compl.”) ¶¶ 6, 21.) Perez claims that he received the vaccine in two doses, on December 22, 2020, and January 19, 2021. (Id. ¶ 37; see also Doc. 132 (“Report”) at 2.) Immediately after receiving the first dose of the vaccine, Plaintiff states that he began suffering from a host of medical issues, including migraines, non- alcoholic fatty liver disease, and persistent peroneal vein thrombosis in his right calf, all of which

Plaintiff attributes to the vaccine. (Am. Compl. ¶¶ 31, 33.) In February 2021, the director of the vaccine study informed Plaintiff that he had not received the vaccine and instead received a placebo. (Id. ¶ 29.) Plaintiff alleges that the portion of his medical record indicating he received a placebo is fraudulent and was created as part of a broader conspiracy. (Id. ¶¶ 22, 29.) Plaintiff then filed a claim through the Health Resources & Services Administration’s Countermeasures Injury Compensation Program (“CICP”), (id. ¶¶ 27, 35), which is a federal program that compensates serious injuries or deaths that occur because of the administration of certain countermeasures during public health emergencies, (see Report at 3 (citing 42 U.S.C. § 247d-6e; 42 C.F.R. § 110)). The COVID-19 vaccine was declared a “covered countermeasure” on March 17, 2020, pursuant to the Public Readiness and Emergency Preparedness Act (“PREP Act”). Id. (citing 85 Fed. Reg. 15,198, at 15202 (Mar. 17, 2020).) CICP requested additional information and records from Plaintiff about his claim, and Plaintiff in turn filed a HIPPA request with the VA Medical Records Office requesting documentation of his participation in the

AstraZeneca study. (Am. Compl. ¶¶ 43–45.) On September 13, 2023, the VA Medical Records Office denied Plaintiff’s request due to his failure to properly complete the necessary paperwork. (See Doc. 1-1 at 6.) Based on these events, Plaintiff asserts that his CICP claim is being “deliberately obstructed” by members of the federal government. (Am. Compl. ¶ 21.) Plaintiff alleges the existence of a widespread racketeering conspiracy between all Defendants to cover up experimentation on veterans through the COVID-19 vaccination program. (Id. at 9; see also id. ¶¶ 29, 35.) He claims his medical records have been deliberately altered as part of a cover-up of the conspiracy, and that certain Defendants have illegally cloned his electronic devices and

iCloud, allowing them to delete and alter his records. (Id. ¶¶ 27, 29, 35, 38.) Procedural History On January 16, 2024, pro se Plaintiff filed his complaint. (Doc. 1.) That same day, Plaintiff filed a consent to receive electronic service through the ECF system. (Doc. 4.) On April 3, 2024, I referred this case to Magistrate Judge Robyn F. Tarnofsky for general pretrial management. (Doc. 25.) On April 9, 2024, the referral was reassigned to Magistrate Judge Sarah Netburn. On April 25, 2024, Plaintiff filed an Amended Complaint against various Defendants, including Dr. Neil C. Evans, Carol Johnson, Dr. Mark J. Mulligan, George Reed Grimes, Damian Williams, AstraZeneca LP, AstraZeneca AB, AstraZeneca UK Lmdt, Melanie Jay, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Ltd. (Am. Compl.) On September 6, 2024, Defendant Mark J. Mulligan moved to dismiss Plaintiff’s Amended Complaint. (Doc. 99.) The same day, Defendants AstraZeneca AB, AstraZeneca Pharmaceuticals LP, and AstraZeneca UK Ltd. (collectively, the “AstraZeneca Defendants”) also moved to dismiss, (Doc. 101), as did Defendants Neil C. Evans, George Reed Grimes, Melanie

Jay, Carol Johnson, and Damian Williams (collectively, the “Federal Defendants”), (Doc. 103). On December 11, 2024, I referred the motions to dismiss to Magistrate Judge Netburn for a Report and Recommendation. (Doc. 125.) On May 15, 2025, Magistrate Judge Netburn issued a thorough 27-page Report and Recommendation (the “Report”), recommending that I grant the motions to dismiss and dismiss Plaintiff’s Amended Complaint with prejudice. (See Report at 26.) The Report notes that because Plaintiff cannot allege new facts to cure the deficiencies in the Amended Complaint, amendment would be futile with respect to all of his claims. (Id. at 24.) On May 22, 2025, I granted Plaintiff’s request to extend his time to object to the Report

to July 14, 2025. (Doc. 135.) On July 14, 2025, Plaintiff filed objections to the Report. (Doc. 136 (“Obj.”).) On July 28, 2025, Defendant Mark Mulligan filed a response to Plaintiff’s objections, (Doc. 138), as did the AstraZeneca Defendants, (Doc. 139). On July 29, 2025, the Federal Defendants filed a response to Plaintiff’s objections. (Doc. 140.) On July 28, 2025, Plaintiff moved for a temporary restraining order. (Doc. 141.) On August 1, 2025, I issued an order informing Defendants that they need not respond to the motion for a temporary restraining order until after I issue my opinion regarding the pending Report. (Doc. 142.) On September 19, 2025, Plaintiff filed a motion “requesting that the Court enter an emergency order directing the immediate preservation of all evidence and information potentially relevant to the above-captioned matter,” (Doc. 144 at 1), in addition to another motion for preservation of evidence, (Doc. 145), and a proposed order granting Plaintiff’s motions, (Doc. 146). Legal Standard

After a magistrate judge issues a report and recommendation, a district court may “accept, reject, or modify, in whole or in part, the findings or recommendations made by the magistrate judge.” 28 U.S.C. § 636(b)(1)(C). “To accept the report and recommendation of a magistrate [judge], to which no timely objection has been made, a district court need only satisfy itself that there is no clear error on the face of the record.” Trs. of Drywall Tapers & Pointers Loc. Union No. 1974 Benefit Funds v. Cite C Corp., No. 17-CV-9304, 2019 WL 1745743, at *1 (S.D.N.Y. Apr. 18, 2019) (internal quotation marks omitted). Where specific objections are made, the court is obligated to review the contested issues de novo. See Fed. R. Civ. P.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Coppedge v. United States
369 U.S. 438 (Supreme Court, 1962)
United States v. Turkette
452 U.S. 576 (Supreme Court, 1981)
Oneida Nation of New York v. Cuomo
645 F.3d 154 (Second Circuit, 2011)
Jackson Dairy, Inc. v. H. P. Hood & Sons, Inc.
596 F.2d 70 (Second Circuit, 1979)
Armco, Inc. v. Penrod-Stauffer Building Systems, Inc.
733 F.2d 1087 (Fourth Circuit, 1984)
Walker v. Vaughan
216 F. Supp. 2d 290 (S.D. New York, 2002)
Wilds v. United Parcel Service, Inc.
262 F. Supp. 2d 163 (S.D. New York, 2003)
Williams v. Dow Chemical Co.
255 F. Supp. 2d 219 (S.D. New York, 2003)
United States v. Gardin
451 F. Supp. 2d 504 (W.D. New York, 2006)
Kallas v. Fiala
591 F. App'x 30 (Second Circuit, 2015)
Denney v. Deutsche Bank AG
443 F.3d 253 (Second Circuit, 2006)
United States v. Thompson
921 F.3d 82 (Second Circuit, 2019)
Sartor v. Toussaint
70 F. App'x 11 (Second Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
Eric Andrew Perez v. Dr. Neil C. Evans, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/eric-andrew-perez-v-dr-neil-c-evans-et-al-nysd-2025.